Other Liabilities - Theriva Biologics Inc (F:SFY) - Alpha Spread

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc Logo
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR Market Closed
Market Cap: 41.8m EUR
Have any thoughts about
Theriva Biologics Inc?
Write Note

Theriva Biologics Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Theriva Biologics Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Theriva Biologics Inc
F:SFY
Other Liabilities
$8.4m
CAGR 3-Years
325%
CAGR 5-Years
66%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.4B
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$2.2B
CAGR 3-Years
-28%
CAGR 5-Years
-22%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$4.6B
CAGR 3-Years
-19%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.5B
CAGR 3-Years
30%
CAGR 5-Years
57%
CAGR 10-Years
37%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.7B
CAGR 3-Years
37%
CAGR 5-Years
11%
CAGR 10-Years
23%

See Also

What is Theriva Biologics Inc's Other Liabilities?
Other Liabilities
8.4m USD

Based on the financial report for Mar 31, 2024, Theriva Biologics Inc's Other Liabilities amounts to 8.4m USD.

What is Theriva Biologics Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
66%

Over the last year, the Other Liabilities growth was 17%. The average annual Other Liabilities growth rates for Theriva Biologics Inc have been 325% over the past three years , 66% over the past five years .

Back to Top